Metabolic syndrome includes pre-diabetes, dyslipidemia, overweight and obesity and hypertension. Metabolic syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Informed and written consent for participation in the study / Body mass index (BMI) above 27 / Having three signs of the five characteristics of the metabolic syndrome based on the definitions of NCEP-ATPIII
Exclusion criteria
Exclusion criteria: Use of extra- protocol treatments / Use of drugs associated with treatment of metabolic syndrome in the past month / Safflower allergy /positive history of kidney, liver, cancer, thyroid and/or coagulation disease / pregnancy and/or lactation / smoking, alcohol and/or substance abuse / Taking anti-platelet and anticoagulant drugs (such as Aspirin, Clopidogrel, Warfarin, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of people with hypertension. Timepoint: Measuring hypertension at the beginning of the study (before the intervention) and 1, 2 and 3 months after the onset of intervention. Method of measurement: Automated sphygmomanometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Composition of body components. Timepoint: Measurement at the beginning of the study (before the intervention) and 12 weeks after intervention. Method of measurement: Medical body Composition Analyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences